Natalie K. Wolf

3.1k total citations · 2 hit papers
23 papers, 1.6k citations indexed

About

Natalie K. Wolf is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Natalie K. Wolf has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Natalie K. Wolf's work include Immune Cell Function and Interaction (8 papers), interferon and immune responses (4 papers) and CRISPR and Genetic Engineering (3 papers). Natalie K. Wolf is often cited by papers focused on Immune Cell Function and Interaction (8 papers), interferon and immune responses (4 papers) and CRISPR and Genetic Engineering (3 papers). Natalie K. Wolf collaborates with scholars based in United States, Germany and Hong Kong. Natalie K. Wolf's co-authors include David H. Raulet, Djem Kissiov, Ramnik J. Xavier, Gregory M. Barton, Eric Brown, Krystal L. Ching, Meghan A. Koch, Christopher J. Nicolai, Damian R. Plichta and Daniel B. Graham and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Natalie K. Wolf

22 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis

2019 397 citations Eduard Ansaldo, Krystal L. Ching et al. Science profile →
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy

2022 318 citations Natalie K. Wolf, Djem Kissiov et al. Nature reviews. Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalie K. Wolf United States	14	804	679	397	156	154	23	1.6k
Lucia Sfondrini Italy	26	831 1.0×	884 1.3×	571 1.4×	199 1.3×	88 0.6×	70	2.1k
Doreen M. Floß Germany	25	711 0.9×	792 1.2×	514 1.3×	121 0.8×	83 0.5×	61	1.8k
Scott McComb Canada	18	888 1.1×	693 1.0×	315 0.8×	133 0.9×	100 0.6×	33	1.5k
Pyeung-Hyeun Kim South Korea	24	681 0.8×	612 0.9×	237 0.6×	186 1.2×	77 0.5×	75	1.6k
Zheng Xiang China	21	461 0.6×	697 1.0×	258 0.6×	131 0.8×	88 0.6×	57	1.4k
Qun Gao China	22	646 0.8×	499 0.7×	521 1.3×	284 1.8×	110 0.7×	106	1.6k
Claudia Maletzki Germany	23	432 0.5×	341 0.5×	493 1.2×	226 1.4×	100 0.6×	85	1.4k
Kazuyuki Furuta Japan	19	711 0.9×	878 1.3×	301 0.8×	128 0.8×	94 0.6×	58	1.7k
Zhongde Ye United States	21	761 0.9×	575 0.8×	259 0.7×	185 1.2×	164 1.1×	26	1.6k
Michele Sommariva Italy	22	819 1.0×	609 0.9×	819 2.1×	177 1.1×	75 0.5×	61	1.9k

Countries citing papers authored by Natalie K. Wolf

Since Specialization

Citations

This map shows the geographic impact of Natalie K. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie K. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie K. Wolf more than expected).

Fields of papers citing papers by Natalie K. Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie K. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie K. Wolf. The network helps show where Natalie K. Wolf may publish in the future.

Co-authorship network of co-authors of Natalie K. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie K. Wolf. A scholar is included among the top collaborators of Natalie K. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie K. Wolf. Natalie K. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nicolai, Christopher J., et al.. (2024). Cytosolic bacterial pathogens activate TLR pathways in tumors that synergistically enhance STING agonist cancer therapies. iScience. 27(12). 111385–111385. 4 indexed citations

Wagstaff, Danielle, Natalie K. Wolf, & Naomi Smith. (2024). Comparing, competing, and the good mum ideology—Maternal well-being in the context of social media.. Evolutionary Behavioral Sciences. 1 indexed citations

Kissiov, Djem, Sean Chen, Natalie K. Wolf, et al.. (2022). Binary outcomes of enhancer activity underlie stable random monoallelic expression. eLife. 11. 9 indexed citations

Wolf, Natalie K., Djem Kissiov, & David H. Raulet. (2022). Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nature reviews. Immunology. 23(2). 90–105. 318 indexed citations breakdown →

Li, Ming O., Natalie K. Wolf, David H. Raulet, et al.. (2021). Innate immune cells in the tumor microenvironment. Cancer Cell. 39(6). 725–729. 108 indexed citations

Kim, Jung, Hsiu‐Chun Chuang, Natalie K. Wolf, et al.. (2021). Tumor-induced disruption of the blood-brain barrier promotes host death. Developmental Cell. 56(19). 2712–2721.e4. 43 indexed citations

Wolf, Natalie K., Cristina Blaj, Lora K. Picton, et al.. (2021). 584 Powerful synergistic effects of a STING agonist and the IL-2 superkine, H9, in eliciting NK and T cell responses against MHC I- and MHC I+ tumors. Regular and Young Investigator Award Abstracts. A614–A614. 1 indexed citations

Yang, Jianbo, Qianjin Liao, Matt A. Price, et al.. (2021). Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation. Translational Oncology. 16. 101318–101318. 14 indexed citations

Kaufmann, Gabriel, Madison T. Weg, Natalie K. Wolf, et al.. (2021). Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development. Cancers. 13(7). 1584–1584. 7 indexed citations

10.

Wolf, Natalie K., Michael Bußmann, Tino Polen, et al.. (2020). Molecular Basis of Growth Inhibition by Acetate of an Adenylate Cyclase-Deficient Mutant of Corynebacterium glutamicum. Frontiers in Microbiology. 11. 87–87. 13 indexed citations

11.

Ansaldo, Eduard, Krystal L. Ching, Meghan A. Koch, et al.. (2019). Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science. 364(6446). 1179–1184. 397 indexed citations breakdown →

12.

Rahrmann, Eric P., Natalie K. Wolf, George M. Otto, et al.. (2018). Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma. Molecular Cancer Research. 17(2). 567–582. 14 indexed citations

13.

Kurata, Morito, Natalie K. Wolf, Walker S. Lahr, et al.. (2018). Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays. PLoS ONE. 13(9). e0198714–e0198714. 49 indexed citations

14.

Scott, Milcah C., Nuri A. Temiz, Anne E. Sarver, et al.. (2017). Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma. Cancer Research. 78(2). 326–337. 84 indexed citations

15.

Wolf, Natalie K., et al.. (2017). In vitro biosynthesis of 3-mercaptolactate by lactate dehydrogenases. Enzyme and Microbial Technology. 108. 1–10. 11 indexed citations

16.

Temiz, Nuri A., Branden S. Moriarity, Natalie K. Wolf, et al.. (2015). RNA sequencing of Sleeping Beauty transposon-induced tumors detects transposon-RNA fusions in forward genetic cancer screens. Genome Research. 26(1). 119–129. 23 indexed citations

17.

Heider, Sabine A. E., et al.. (2014). Optimization of the IPP Precursor Supply for the Production of Lycopene, Decaprenoxanthin and Astaxanthin by Corynebacterium glutamicum. Frontiers in Bioengineering and Biotechnology. 2. 28–28. 68 indexed citations

18.

Rahrmann, Eric P., Adrienne L. Watson, Vincent W. Keng, et al.. (2013). Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nature Genetics. 45(7). 756–766. 108 indexed citations

19.

Wolf, Natalie K., et al.. (2013). DSABR : Di stributed System for Automated Blender Rendering. Minds at UW (University of Wisconsin).

20.

Trentin, J. J., et al.. (1967). Antibody Production by Mice Repopulated with Limited Numbers of Clones of Lymphoid Cell Precursors. The Journal of Immunology. 98(6). 1326–1337. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact